2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …

Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research

VARC-3 Writing Committee, P Généreux… - European heart …, 2021 - academic.oup.com
Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

H Baumgartner, V Falk, JJ Bax… - Polish Heart …, 2018 - journals.viamedica.pl
Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …

Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial)

P Green, SV Arnold, DJ Cohen, AJ Kirtane… - The American journal of …, 2015 - Elsevier
Transcatheter aortic valve replacement (TAVR) is an effective treatment for severe
symptomatic aortic stenosis (AS) in patients who are inoperable or at high risk for surgery …

TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation

R Puri, B Iung, DJ Cohen… - European heart …, 2016 - academic.oup.com
Transcatheter aortic valve implantation (TAVI) has spawned the evolution of novel catheter-
based therapies for a variety of cardiovascular conditions. Newer device iterations are …

Older adults in the cardiac intensive care unit: factoring geriatric syndromes in the management, prognosis, and process of care: a scientific statement from the …

AA Damluji, DE Forman, S Van Diepen, KP Alexander… - Circulation, 2020 - Am Heart Assoc
Longevity is increasing, and more adults are living to the stage of life when age-related
biological factors determine a higher likelihood of cardiovascular disease in a distinctive …

Cardiac imaging for assessing low-gradient severe aortic stenosis

MA Clavel, IG Burwash, P Pibarot - JACC: Cardiovascular Imaging, 2017 - jacc.org
Up to 40% of patients with aortic stenosis (AS) harbor discordant Doppler-
echocardiographic findings, the most common of which is the presence of a small aortic …